LUMISIGHT FDA approval date

The FDA approved LUMISIGHT on 17 Apr 2024.

FDA approval date
17 Apr 2024

Drug identity has not yet been verified against registry records

Also recorded as PEGULICIANINE ACETATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-04-17DayLUMISIGHTFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA214511", "applicant_as_listed_by_fda": "LUMICELL", "brand_names": ["LUMISIGHT"], "active_ingredients": ["PEGULICIANINE ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240417", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026